The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pandiyan, P.
Right arrow Articles by Brunner-Weinzierl, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pandiyan, P.
Right arrow Articles by Brunner-Weinzierl, M. C.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
The Journal of Immunology, 2007, 178: 2132-2140.
Copyright © 2007 by The American Association of Immunologists, Inc.

High IFN-{gamma} Production of Individual CD8 T Lymphocytes Is Controlled by CD152 (CTLA-4)1

Pushpa Pandiyan2,3,*, J. Kolja E. Hegel3,*, Manuela Krueger{dagger}, Dagmar Quandt* and Monika C. Brunner-Weinzierl4,*

* Charité-Universitätsmedizin Berlin, Deutsches Rheumaforschungszentrum, Berlin, Germany; and {dagger} Deutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
CD8 T cell expansion and cytokine production is needed to generate an effective defense against viral invasion of the host. These features of CD8 T lymphocytes are regulated, especially during primary responses, by positive and negative costimulation. We show in this study that surface expression of CD152 is highly up-regulated on activated CD8 T lymphocytes during primary immune responses, suggesting a prominent regulatory role. Indeed, production of the proinflammatory cytokine IFN-{gamma}, but not TNF-{alpha}, by CD8 T cells was inhibited by CD152 engagement. The inhibition was regulated independent of proliferation and IL-2 production, but dependent on the quality of the TCR signaling. We show that signals induced by CD152 on activated CD8 T lymphocytes reduce the frequency of IFN-{gamma}high-expressing cells. Our data also show that in activated CD8 T cells, the CD152-mediated inhibition of cytokine production is more pronounced than inhibition of their proliferation.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
CD8+ T lymphocytes play a crucial role in protection from intracellular pathogens such as viruses. The key effector cytokine produced by CD8 T cells is IFN-{gamma}. Pleiotropic actions of IFN-{gamma} induce diverse effects on a wide range of target cells that include induction of both specific and nonspecific mechanisms of host defense against infectious agents and tumors. IFN-{gamma} is one of the major cytokines responsible for up-regulating MHC class I and II proteins on a variety of cells such as macrophages and epithelial cells (1, 2). In addition, this cytokine regulates humoral immune responses by affecting IgG H chain switching in both a direct and indirect manner (3, 4). It has been shown that IFN-{gamma} produced by CD8+ T cells acts directly on CD4+ Th1 differentiation (5). In addition, IFN-{gamma} regulates the production of a variety of other proinflammatory cytokines including IL-12 and TNF-{alpha} and stabilizes inflammatory T cell responses (5, 6). Disruption of IFN receptor {gamma}-chain expression in mice in vitro and in vivo impaired the ability of these mice to resist infections by a variety of microbial pathogens including Listeria monocytogenes, Leishmania major and several species of mycobacteria despite the fact that the mice developed normal helper and cytotoxic T cell responses to these pathogens (7, 8, 9). This result demonstrates that IFN-{gamma} plays a critical role in the expression of innate host resistance to microbial infections. These studies also clearly identified an important role for IFN-{gamma} in promoting tumor immunogenicity (10). Generally, proinflammatory cytokines are a major control switch to initiate as well as maintain inflammatory responses.

CTLA-4 (CD152) is a major down-regulator of immune responses (11, 12). Although CD152 was discovered initially as mRNA that is preferentially transcribed in CD8+ T cells, it can also be detected in activated CD4+ lymphocytes (13, 14). The inhibitory role of CD152 became strikingly evident in CD152-deficient mice, which suffer from a lymphoproliferative disease of highly activated CD4 T lymphocytes. Under suboptimal stimulatory conditions, CD152 probably inhibits the early stages of TCR signaling in general by preventing formation of membrane lipid rafts, inhibiting accumulation of IL-2 mRNA, preventing nuclear translocation of the transcription factor NF-AT, inducing G1 cell cycle arrest in an IL-2-independent manner, and diminishing expression of activation-associated receptors such as CD69 and CD25 (11, 15, 16). In addition, at the peak of surface CD152 expression on activated CD4 T cells, CD152 regulates expansion of these proliferating cells and induces resistance against apoptosis (17, 18). CD8 T lymphocytes are not affected in CD152–/– mice, which implies a different effect of CD152 on CD4 and on CD8 T cells. Moreover, it has been shown that CD152 is involved in inducing anergy in CD4 T cells (19), but not in CD8 T cells, rather CD152 has been shown to function synergistically with programmed death-1 (20, 21). Thus far, detection of CD152 on the surface of primary T cells by conventional techniques has been difficult due to low levels of surface expression. In MHC class-I-restricted CD152–/– animals, like in 2C-TCRtg mice, CD8 T cells maintain a naive phenotype in young animals (22). Nevertheless, CD152 is expressed and is functional at the cell surface on activated CD8 T cells from wild-type (WT)5 and 2C-TCRtg mice (14, 23). Proliferation in response to anti-CD3 and anti-CD28 in vitro can be inhibited by CD152 cross-linking (11, 14, 24). Previous studies imply that CD152 regulates secondary recall responses but not primary immune responses (22), suggesting that CD152 plays a regulatory role only in differentiated CD8 lymphocytes. Specifically, expansion but not differentiation is regulated by CD152, which leads to an overall reduction in cytokine secretion due to reduced numbers of effector cells, but not due to reduced cytokine secretion of individual cells (22). In addition, it has been shown that CD152 signaling on CD8 T lymphocytes has no significant function in vivo (25, 26). Therefore, regarding primary CD8 T lymphocyte responses, the precise function of CD152 is largely undefined.

In this study, we investigated the functional role of CD152 in primary CD8 T cells upon antigenic or polyclonal stimulation. We show here that CD152 differentially regulates IFN-{gamma} production but not cell cycle progression and that inhibition of the proinflammatory cytokine IFN-{gamma} is regulated by CD152 engagement in a cell autonomous manner. This novel function of CD152 activation on CD8 T cells may be important in preventing potentially hazardous inflammatory reactions while maintaining viral and tumor immunogenicity.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 Disclosures
 References
 
Mice

OVA-specific TCRtg mice (OT-1 and OT-2) both CD152WT and CD152–/–, lymphocytic choriomeningitis virus-specific TCRtg mice (P14), and C57BL/6 mice were bred under specific pathogen-free conditions in the animal facility of the Bundesgesundheitsamt (Berlin, Germany) or in Institute of Experimental Immunology (Zürich, Switzerland). All mice were used at the age of 5–8 wk, and offsprings of OT-1, CD152–/– mice were genotyped by PCR using oligonucleotide primers (CD152, 5'-TGGAGTCCTTCATAGTTAGG and CD152, 3'-GCAAGATGGTGAGTGTGATGTT; Neo, 5'-CATAGTTAGGTCTGTGATGC and Neo, 3'-CGTCAAGAAGGCGATAGAAGGC). All mice have been backcrossed onto the C57BL/6 strain for >10 generations. All animal experiments were performed with age- and sex-matched controls in accordance with institutional, state, and federal guidelines.

Abs, cytokines, and reagents

The following Abs against murine Ags were used: {alpha}nti-CD152 (UC10-4F10-11), V{alpha}2-TCR (B20.1), and IFN-{gamma}R (2E2) (BD Biosciences) in their respective form of FITC, PE-, Cy5-, or biotin-conjugates. Annexin V-PE was purchased from BD Biosciences. Anti-CD3 (145-2C11), anti-CD8 (196), anti-CD44 (IM7), anti-CD62L (MEL14), and anti-IFN-{gamma} (AN18.17.24) were purified from hybridoma supernatants with protein G and controlled by HPLC, PAGE, and FACS analysis. Control Abs such as IgG1 (R3-34) and FITC-conjugated hamIgG2 (anti-KLH, HA4/8) were purchased from BD Biosciences. Magnetic microbeads anti-CD8, anti-CD62L, anti-CD90, and anti-FITC were purchased from Miltenyi Biotec. Murine IL-2 was used from culture supernatants of transfected mouse cell line X63-IL-2.6. Concentration and bioactivity was determined by ELISA and IL-2-dependent mouse cell line CTLL-2. Abs and Fab were controlled using HPLC analysis showing routinely only one peak. Neutralizing anti-CD152 Fab were prepared from whole Abs with Immunopure Fab preparation Kit (Pierce) and were used at 200 µg/ml in cell cultures. Specificity of anti-CD152 Abs were controlled by FACS staining. Toxicity and function of Fab was tested in Ag-stimulated T cell cultures using trypan blue. Anti-CD152 Fab were used when at least twice as much CD4 T lymphocytes were detected upon Ag-specific stimulation in cultures treated with anti-CD152 Fab compared with cultures treated with control Fab. PMA, ionomycin, and brefeldin A were purchased from Sigma-Aldrich and used in following concentrations: PMA (10 ng/ml), ionomycin (0.5 µg/ml), and brefeldin A (10 µg/ml).

Preparation of liposomes

Large unilamellar vesicles were prepared as described by Hope et al. (27). Briefly, 300 µmol of a mixture of lipids (molar ratio DPPC:Chol:DPPG:PDP-DPPE = 45:40:10:5) dissolved in chloroform and glass beads were deposited in a glass vessel. Additionally, we added the flourescic lipophil dye Cy5 (D7757; Molecular Probes) in a concentration of 0.23 µM. The solvent was allowed to evaporate and the remaining lipid film was dried under vacuum for 1 h at 65°C. The lipids were then hydrated at 65°C with ~4 ml of PBS (pH 7.5) containing 10 mM chloroform and magnetic beads. The suspension was submitted to several freeze-thaw cycles and extruded 5–10 times through filters of 800- and, subsequently, 400-nm pore size (Millipore). Liposomes were separated from free magnetic particles by centrifugation over a Ficoll (Pharmacia) density gradient. Liposomes containing magnetic particles were then isolated by high-gradient magnetic field filtration, with the MACS system (Miltenyi Biotec). Size distribution was estimated by measuring the relative fluorescence intensity of the different liposome fractions by flow cytometry.

Conjugation of Abs to liposomes

Anti-digoxigenin Fab (1 mg/ml in carbonate buffer; pH 8.5) were modified with DTT. The product was isolated by gel chromatography on a Sephadex G20 column (PD10; Pharmacia), equilibrated with PBS. The modified protein was stored at –20°C until used. For conjugation, the liposomes were first activated with NHS-sulfo-SMCCm and then incubated with the modified protein at a final concentration of 0.5 mg/ml and gently stirred for 1 h. Unconjugated protein was then removed from liposomes by gel chromatography on Sepharose CL4B (Pharmacia).

Cell isolation and stimulation

Isolation of naive CD8+CD44low T cells was performed using two-parameter high-gradient MACS and FACS. Splenocytes from OVA-specific TCRtg mice were incubated with anti-CD8 magnetic microbeads according to the manufacturer’s instructions and enriched to a purity of >95%. Subsequently, they were sorted by FACS DiVa (BD Biosciences) for CD44low phenotype with mAb anti-CD44-conjugated to FITC or Cy5. By this procedure, CD8+CD44low cells were purified to >99.9% as determined by flow cytometry. Isolated cells were stimulated either with 1 µg/ml SIINFEKL (OVA257–264) peptide (Mimotopes) or with anti-CD3 (2 µg/ml) and APCs at a final cell density of 3 x 106 cells/ml, the medium being RPMI 1640 with added 10% FCS, 0.3 mg/ml glutamine, and 10 µM 2-ME. T cell-depleted splenocytes from congenic C57BL/6 mice were used as APCs such that CD8:APC ratio was 1:6. Cells were allowed to proliferate and were expanded with IL-2 (50 U/ml) added during splitting of cells on day 3 after primary stimulation. Secondary stimulation was done on day 9–12 after primary stimulation with 1 µg/ml SIINFEKL (OVA257–264) peptide, APCs, and IL-2 (50 U/ml). Isolation of naive CD62LhighCD4+ T cells was performed using MACS. Splenocytes from OVA-specific TCRtg mice were incubated with FITC-conjugated anti-CD4 mAb and subsequently with MultiSort anti-FITC microbeads (Miltenyi Biotec) according to the manufacturer’s instructions. CD4+ cells were isolated by positive selection on an autoMACS system (Miltenyi Biotec) to a purity of >99.3%. After the release of MultiSort anti-FITC microbeads, CD4+ cells were incubated with anti-CD62L microbeads. CD62LhighCD4+ cells were positively selected on autoMACS to a purity of >99% as determined by flow cytometry. Isolated cells were stimulated with 1 µg/ml OVA323–339 peptide (Neosystem) and APCs and expanded as described for CD8 T cells above. Cell stimulation was done with indicated concentrations of peptide or Ab as described above unless otherwise specified. T cells were removed by depletion of CD90+ cells after incubation with anti-CD90 microbeads and subsequent negative selection. To ensure that an equal number of CD8 cells were stimulated in both CD152–/– and CD152WT cultures, flow cytometric true-count analyses were performed with Fluoresbrite YG latex microspheres (Polysciences) 12 h after primary stimulation.

Measurement of cell cycling, cytokines, and apoptosis

Cell cycle progression was measured by labeling T cells with CFSE (Molecular Probes). In brief, 1 x 107 cells/ml were washed with PBS and stained with CFSE (5 µM in PBS) for 6 min at room temperature in the dark. The reaction was stopped by resuspending the cells in RPMI 1640 medium with 10% FCS. TNF-{alpha} and IFN-{gamma} were detected in culture supernatants by ELISAs using DuoSet (R&D Systems) with a lower detection limit of 20 pg/ml. Intracellular stainings were performed in fixed cells incubated with brefeldin A for 4 h before fixation unless specified otherwise. Fixation and permeabilization of cells was performed using the Cytofix/Cytoperm kit from BD Biosciences.

To reproducibly count cell numbers in stimulated WT and knockout (KO) cultures by FACS, Fluoresbrite YG latex microspheres 20.0 µm (Polysciences) were used. A defined number of Fluoresbrite microspheres was added to cell culture suspensions previously stained for CD8-positive cells with a fluorescent-conjugated Ab. By comparing the known concentration of Fluoresbrite microspheres with the number of CD8-positive events, absolute cell counts could be evaluated. The binding of Annexin V-PE (BD Biosciences) was used to follow phosphatidylserine exposition on early apoptotic cells. The staining was performed according to the manufacturer’s instructions. Briefly, 3 x 105 cells/ml were incubated with saturating concentrations of Annexin V-PE for 20 min at room temperature and immediately analyzed by flow cytometry. Late apoptotic cells were counter stained by propidium iodide (Invitrogen Life Technologies).

Four-color cytometric analysis of surface expression of CD152

Surface expression of CD152 was detected using magnetofluorescent liposomes (17). T cells were incubated with unconjugated hamster anti-CD152 Ab at a concentration of 1 µg/ml for 15–20 min at 4°C. Then, cells were washed twice and incubated with Cy5 dye-filled liposomes, conjugated to anti-ham Fab for 30 min at 4°C. Unbound liposomes were removed by washing the cells thrice with PBS-BSA. The specificity of CD152 staining was controlled by isotype control Ab conjugated with Cy5-filled liposomes as well as by incubation of cells with Cy5-filled liposomes only. Cytometric analyses were performed using a FACSCalibur (BD Biosciences) and FlowJo (Tree Star) software. Dead cells were excluded by forward and sideward scatter gating and propidium iodide staining in surface staining analyses.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 Disclosures
 References
 
Large number of activated CD8 T lymphocytes express CD152 on the cell surface

CD152 is not expressed on the surface of resting T cells and is difficult to detect even after stimulation of T cells (24, 28, 29). To analyze CD152 expression on the surface of CD4 and CD8 cells, we stimulated naive OVA-specific CD4+ or CD8+ TCRtg T cells with their respective antigenic peptide OVA323–339 or OVA257–264, respectively, in the presence of congenic APCs. Enrichment of primary, naive CD44lowCD8+ T cells resulted in a purity of ≥99.9% (Fig. 1A), and enrichment of primary, naive CD62L+CD4+ T cells resulted in a purity of 99%. To unambiguously identify T cells expressing surface CD152, we used an enhanced staining technique (30) based on CD152-specific immunofluorescent liposomes, which increased the detection sensitivity of surface CD152 at least 1000-fold (31). Using this optimized method, expression of surface CD152 was evaluated at different time points after the onset of primary activation of CD4+ and CD8+ T cells (Fig. 1, B and C). Specificity controls revealed <2% unspecific staining in Ag-stimulated T cells (Fig. 1, B and C). The surface expression of CTLA-4 on CD8 cells starts 48 h after activation, reaches maximal expression with up to 60% CD152+ cells between day 4 and 5, and can still be detected at day 8 (Fig. 1, B and C). In contrast to this, the surface expression of CD152 on CD4 cells peaks already between day 2 and 3 when at most 12% CD152+ cells are detectable, rapidly declines, and is barely detectable on day 5 (Fig. 1C). Thus, both primary activated CD4 and CD8 T cells are able to express surface CD152, but it is expressed at a 2- to 6-fold higher frequency in CD8 cells and retained at the cell surface much longer, indicating that CD152 might play a more prominent role in CD8 cells.


Figure 1
View larger version (35K):
[in this window]
[in a new window]

  		FIGURE 1. Ag-specific stimulated CD8 cells show higher frequencies of surface CD152+ cells compared with CD4 cells. A, Representation of naive CD8+CD44low cell sorting of CD152-WT and -KO cells by FACS. The upper panels show the MACS-enriched CD8+ T cell population. The lower panels represent the subsequently naive sorted CD8+CD44low fractions, which at the same time are CD62L+. B, Frequency of CD152 expression as measured by liposome immunostaining. Naive (CD8+CD44low) OVA-specific CD8+ T cells from OT-1 mice were stimulated with the peptide OVA257–264 and congenic APCs, as described in Materials and Methods. Expression of surface CD152 was evaluated with liposome immunostaining on day 3 after primary stimulation, left panel shows control staining performed with isotype-matched Ab. C, Kinetics of CD152 surface expression on CD8 and CD4 cells as monitored by liposome immunostaining during days 1–8 after onset of primary stimulation. For analyzing CD152 expression on CD8 cells, naive cells were stimulated and analyzed as in B. Naive CD62LhighCD4+ T cells from OT-2 mice were isolated and stimulated with Ag and APC. Expression of surface CD152 was evaluated at time points after the onset of primary stimulation as indicated. Data in C show values subtracted from isotype controls. No CD152 was expressed in the absence of Ag. One of three independent experiments is shown.

 
CD152 down-regulates IFN-{gamma} secretion of Ag-specific activated CD8 lymphocytes

IFN-{gamma} is one of the most important effector cytokines of cytotoxic CD8 T cells, which has been shown to be unaffected by CD152 during primary stimulation (22). Naive CD8 cells from CD152WT or CD152–/– OT-1 mice were stimulated with Ag and congenic APCs, and concentrations of IFN-{gamma} were monitored in the supernatants collected at different time points after the onset of a primary stimulation. To ensure that equal numbers of CD8 cells were stimulated in both CD152–/– and CD152WT cultures, flow cytometric analyses were performed with Fluoresbrite microspheres on CD8 TCRtg T lymphocytes 12 h after primary stimulation. It was consistently observed at all time points analyzed (days 0–7) (Fig. 2A) that the IFN-{gamma} concentration in supernatants of Ag-stimulated CD152–/– CD8 lymphocytes were at least 5–7 times higher than those of CD152WT CD8 lymphocytes. Cytometric detection of IFN-{gamma}R revealed similar surface expression in both populations (data not shown). The titration of Ag for stimulation (0–10 µg/ml) showed that the IFN-{gamma} concentration in supernatants was enhanced in CD152–/– CD8 populations as compared with CD152WT ones in a dose-dependent manner (Fig. 2B). Because CD152 regulates IL-2 production in T lymphocytes and CD8 cells are dependent on IL-2 3 days after the onset of stimulation (23, 24), experiments were conducted both in the presence or absence of IL-2 addition for expansion of CD8 cells. IL-2 addition during expansion of CD8 cells did not affect CD152-mediated down-regulation of IFN-{gamma} levels in CD152WT cultures both after primary (Figs. 2A and 3A) and secondary stimulation (Fig. 3C), showing that the inhibitory effect of CD152 on IFN-{gamma} is independent of IL-2. Enhanced cell death of Ag-specific stimulated CD152WT CD8 cells was also excluded to account for lower IFN-{gamma} concentrations in their culture supernatants (Fig. 2D). To further investigate whether the down-regulatory effect of CD152 on IFN-{gamma} was dependent on a certain signaling quality of the TCR-complex, naive CD8 cells were stimulated with soluble anti-CD3 plus APCs, and supernatants were analyzed for IFN-{gamma} at different time points after the onset of the primary stimulation. Results from ELISA showed that anti-CD3 plus APC-stimulated CD152WT and CD152–/– cultures have comparable levels of IFN-{gamma} in their supernatants at all time points analyzed (Fig. 2C). Thus, CD152 regulates IFN-{gamma} secretion both in primary and secondary stimulated CD8 cultures. However, this action depends on the quality of the TCR signaling cascade because only Ag-specific stimulated CD8 T cells showed this response.


Figure 2
View larger version (29K):
[in this window]
[in a new window]

  		FIGURE 2. CD8 T cell culture supernatants of Ag-specific stimulated CD152–/– have higher concentrations of IFN-{gamma} compared with CD152WT cultures. Naive (CD8+CD44low) OVA-specific CD8+ T cells from CD152WT or CD152–/– OT-1 mice were stimulated with the peptide OVA257–264 (A, B, and D) or anti-CD3 (C) and congenic APCs. A, IFN-{gamma} levels in the supernatant were evaluated after primary stimulation of CD8 T cells with the peptide OVA257–264 at the time points indicated. B, Dose response of IFN-{gamma} in the supernatant evaluated on day 4 after primary stimulation of CD8 T cells stimulated with indicated Ag concentrations. C, IFN-{gamma} levels in the supernatant were evaluated after primary stimulation of CD8 T cells with anti-CD3 and congenic APCs at the time points indicated. D, Ag- induced cell death in CD152WT and CD152–/– CD8 T cells during primary stimulation. CD152WT and CD152–/– CD8 T cells undergo equal levels of activation-induced cell death during primary stimulation. Annexin V stainings were performed at the indicated time points. Data here represent one of two to four independent experiments.

 

Figure 3
View larger version (29K):
[in this window]
[in a new window]

  		FIGURE 3. Ag-specific stimulated CD152–/– CD8 culture supernatants show higher TNF-{alpha} only during secondary stimulation compared with CD152WT cultures. The presence of IL-2 in culture supernatants is not influencing CD152-mediated effects on IFN-{gamma} and TNF-{alpha} production. Naive (CD8+CD44low) OVA-specific CD8+ T cells from CD152WT or CD152–/– OT-1 mice were stimulated by use of peptide OVA257–264 and congenic APCs. IFN-{gamma} and TNF-{alpha} concentrations in the supernatant were evaluated after primary stimulation with IL-2 added on day 3 (A and B) and after secondary stimulation with IL-2 added on day 0 (C and D) at the time points indicated. IFN-{gamma} levels in the culture supernatants were analyzed by ELISA after primary (A) and after secondary stimulation (C). TNF-{alpha} concentrations were evaluated after primary (B) and after secondary stimulation (D). Data here represent results from one experiment of three independent experiments.

 
CD152 down-regulates TNF-{alpha} levels in Ag-restimulated CD8 cultures

TNF-{alpha} is also an important effector and cytotoxic cytokine produced by CD8 cells, which has previously not been studied in relation to CD152. Because of its importance in apoptosis and cytotoxicity in CD8 cells (32), TNF-{alpha} was also monitored in the supernatants collected at different time points after primary stimulation of naive CD8 cells from CD152WT or CD152–/– OT-1 mice. ELISA results showed that at all time points analyzed (days 0–7), TNF-{alpha} levels in Ag-stimulated CD152–/– CD8 cultures were comparable to those in CD152WT cultures in the presence or absence of IL-2 (Figs. 3B and 4A). Corresponding results were likewise observed when CD152WT or CD152–/– CD8 T cells were stimulated with different concentrations of Ag (0–10 µg/ml) and TNF-{alpha} levels monitored on day 4 after primary stimulation (Fig. 4B). In contrast, when ELISAs were performed on supernatants collected after secondary Ag-specific stimulation, cultures of CD152–/– CD8 T cells reproducibly showed at all time points investigated dramatically higher amounts of TNF-{alpha} than those of CD152WT cells (Fig. 3D). Naive CD8 cells were also stimulated with soluble anti-CD3 and APCs, and ELISAs were performed on supernatants collected at different time points after primary stimulation. Results from ELISA also showed that CD3-stimulated CD152WT and CD152–/– cultures reproducibly have comparable levels of TNF-{alpha} in their supernatants at all time points (Fig. 4C). Thus, CD152 regulates TNF-{alpha} levels only in Ag-restimulated CD8 cells.


Figure 4
View larger version (25K):
[in this window]
[in a new window]

  		FIGURE 4. TNF-{alpha} concentrations are similar in CD152–/– compared with CD152WT CD8 culture supernatants after primary stimulation. Naive (CD8+CD44low) OVA-specific CD8+ T cells from CD152WT or CD152–/– OT-1 mice were stimulated with the peptide OVA257–264 (A and B) or anti-CD3 (C) and congenic APCs. A, TNF-{alpha} levels in the supernatant were evaluated after primary stimulation of CD8 cells at the time points indicated. B, Dose response of TNF-{alpha} in the supernatant on day 4 after primary stimulation of CD8 cells stimulated with indicated Ag concentrations. C, TNF-{alpha} levels in the supernatant were evaluated after primary stimulation of CD8 T cells with anti-CD3 and congenic APCs at the time points indicated. Data represent results of more than three independent experiments.

 
CD8 cell proliferation is not suppressed by CD152 during primary stimulation

With respect to proliferation, CD152 has been shown to regulate only secondary and not primary responses. This was shown by thymidin incorporation into all proliferating cells in a mixed APC-CD8 T cell culture (22). To investigate whether increased IFN-{gamma} levels in primary CD152–/–CD8 cultures were due to increased numbers of individual effector CD8 cells in the culture, proliferation was monitored in the CD152WT and CD152–/– cultures at different time points by CFSE labeling of naive cells during the onset of stimulation. CFSE is a vital fluorescent dye incorporated by cells during labeling. Proliferation reduces the intensity of the dye as CFSE is diluted to half in daughter cells. Thus, CFSE intensity can serve to measure the extent of cell divisions of individual cells. The results show that at all time points analyzed (day 0, 2, 4, and 6), there was substantial proliferation in both Ag (Fig. 5A) and CD3-stimulated (Fig. 5B) CD152–/– and CD152WT CD8 T cell cultures. Furthermore, proliferation capacities of both cultures were comparable in the presence or absence of IL-2 (Fig. 5C), which is in concert with previous observations (22). Experiments showed that CD152WT or CD152–/– CD8 cells, even when stimulated with different concentrations of Ag (0.01–10 µg/ml), had comparable proliferation capacities as monitored by CFSE dilution on day 4 after primary stimulation (Fig. 5D). No spontaneous proliferation was observed in both populations without Ag (0 µg/ml). These results show that proliferation was unaffected by CD152 in primary CD8 T cells, and that increased levels of IFN-{gamma} in CD152–/– cultures were not a result of increased numbers of effector cells.


Figure 5
View larger version (35K):
[in this window]
[in a new window]

  		FIGURE 5. Proliferation of Ag-specific stimulated CD152WT and CD152–/– CD8 cells is similar. Naive (CD8+CD44low) OVA-specific CD8+ T cells from CD152WT or CD152–/– OT-1 mice were stimulated with the peptide OVA257–264 (A, C, and D) or anti-CD3 (B) and congenic APCs. A and B, Proliferation of CD8 T cells was evaluated by CFSE dilution at the time points indicated after primary stimulation with Ag (A) or anti-CD3 (B), respectively. C, Proliferation was evaluated at time points indicated by CFSE dilution after primary stimulation with IL-2 added during expansion on day 3 after primary stimulation. D, Dose response of CD8 cells were analyzed for proliferation using CFSE dilution analysis on day 4 after primary stimulation with indicated Ag concentrations. Data represent results of four independent experiments.

 
Frequency of IFN-{gamma}high producers is regulated by CD152 in CD8 cells during primary stimulation

Because augmented levels of IFN-{gamma} in CD152–/– cultures were not due to increased absolute CD8 effector numbers, it would have been possible that either increased frequencies of IFN-{gamma} producers or increased secretion of IFN-{gamma} per cell had caused this effect. To this end, intracellular amounts of IFN-{gamma} were measured in primary CD152WT and CD152–/–CD8 populations at different time points (days 2 and 3) by intracellular cytokine stainings and subsequent flow cytometry (Fig. 6A). Intracellular IFN-{gamma} was observed to be produced by a high fraction of CD8 T cells in both CD152–/– and CD152WT cultures. Interestingly, there was a consistent difference in the mean fluorescence intensity (MFI) of intracellular IFN-{gamma} between CD152–/– CD8 cells and those of CD152WT (Fig. 6A,

Formula

). Monitoring individual cells, the frequency of IFN-{gamma}high producers was 40 to nearly 70% higher in CD152–/– cultures than in CD152WT ones on day 1, 2, 3, and 4 (Fig. 6A; data of day 1 and 4 are not shown). Thus, increased numbers of IFN-{gamma}high producers might contribute to the observed enhanced IFN-{gamma} production when CD152 is genetically inactivated.


Figure 6
View larger version (49K):
[in this window]
[in a new window]

  		FIGURE 6. IFN-{gamma} production by individual CD8 T lymphocytes is inhibited by CD152. A, Naive (CD8+CD44low) OVA-specific CD8+ T cells from CD152WT or CD152–/– OT-1 mice were stimulated by use of peptide OVA257–264 and congenic APCs. Intracellular IFN-{gamma} in CD152WT (WT) and CD152–/– (KO) was detected by flow cytometry on day 2 and day 3. Percentages refer to CD8+ T lymphocytes population. Before fixation, cultures were incubated with PMA, ionomycin, and brefeldin A for 4 h. Control stainings were performed by adding unconjugated Ab of the same specificity in 100-fold excess before staining with the conjugated Ab. C, Naive (CD8+CD44low) CD8+ T cells from OT-1 mice (upper panel) and P14 mice (lower panel) were stimulated together with congenic APCs by use of peptide OVA257–264 and GP33, respectively. Cultures were set up with either CD152-specific or control Fab added. Intracellular IFN-{gamma} was detected by flow cytometry on day 1, 2, and 3. Percentages refer to CD8+ T lymphocyte population. Gray shaded numbers indicate IFN-{gamma} MFI. B, Supernatants of the same cultures shown in C from OT-1 mice (upper panel) and P14 mice (lower panel) were analyzed for IFN-{gamma} concentration by ELISA. One representative result of four independent experiments is shown.

 
To substantiate a role for CD152 in controlling IFN-{gamma} production of CD8 cells, we confirmed our data using serological blockade of CD152 and also TCRtg monoclonal T cells of another specificity (Fig. 6, B and C). Therefore, CD152 was inactivated on CD8 cells of OT-1 and P14 mice, respectively, by adding neutralizing anti-CD152 Fab to CD8 cells during primary stimulation, and IFN-{gamma} production was monitored in the supernatants on day 1, 2, and 3 (Fig. 6, B and C). The specificity of the serological blockade was controlled by adding control Fab to the cultures (Fig. 6B,

Formula

; Fig. 6C, upper panels). Following Ag-specific stimulation of CD8 cells of OT-1 and P14 mice, CD8 cells of both TCRtg mice that were activated under serological blockade of CD152 produced >2-fold more IFN-{gamma} than CD8 cells that received a CD152 signal (Fig. 6B). Detection of IFN-{gamma} producers was performed by analyzing intracellular IFN-{gamma} of CD8 cells without prior PMA/ionomycin stimulation. Monitoring individual cells, the frequency of IFN-{gamma}high producers is 6–20% higher in CD152–/– cultures than CD152WT ones on day 1, 2, and 3 (Fig. 6C). Thus, higher numbers of IFN-{gamma}high producers might contribute to the observed enhanced IFN-{gamma} production when CD152 is serologically inactivated.

To determine that the observed CD152-mediated inhibition of IFN-{gamma} production of CD8 T cells during primary stimulation is not an indirect effect, e.g., mediated by non-CD8 cells participating in the culture, we performed experiments in which CD152WT and CD152–/– CD8 T cells were cocultured. For this test, we labeled either naive CD8 cells from CD152WT or CD152–/– OT-1 mice with CFSE and cocultured them together with their respective unlabeled counterpart CD8 cells. Cultures were stimulated with Ag and congenic APCs. To exclude inhibitory effects of CFSE labeling on production of IFN-{gamma}, the same experiment was conducted vice versa each time analyzing the CFSE–-unlabeled CD8 T cells. By using this experimental approach, we were able to compare intracellular IFN-{gamma} levels of CD152WT and CD152–/– CD8 T cells in the same culture by distinguishing the two populations according to CFSE staining. On days 1 and 2 after primary stimulation, intracellular IFN-{gamma} in CD8 T cells was detected by flow cytometry. As shown in Fig. 7, coculturing of CD152WT and CD152–/– CD8 T cells did not influence the CD152-mediated inhibitory effect on IFN-{gamma}high producers.


Figure 7
View larger version (24K):
[in this window]
[in a new window]

  		FIGURE 7. CD152-mediated inhibition of IFN-{gamma} production is independent of culture conditions. Coculture: naive (CD8+CD44low) OVA-specific CD8+ T cells from CD152WT and CD152–/– OT-1 mice were jointly stimulated by use of peptide OVA257–264 and congenic APCs. Either CD8+ T cells from CD152WT or CD152–/– OT-1 mice were labeled with CFSE. To exclude effects of CFSE labeling on cell metabolism, only the CFSE-negative population was analyzed (CFSE-positive events are not shown). Instead, this experiment was performed vice versa with either CD152WT or CD152–/– OT-1 cells labeled with CFSE to get comparable results. Intracellular IFN-{gamma} in CD152WT (WT) and CD152–/– (KO) was detected by flow cytometry on day 2 and 3. Percentages refer to the CFSE-unlabeled CD8+ T lymphocytes population. Before fixation, cultures were incubated with PMA, ionomycin, and brefeldin A for 4 h. Gray shaded numbers indicate IFN-{gamma} MFI. Control stainings were performed by adding unconjugated Ab of the same specificity in 100-fold excess before staining with the conjugated Ab. One of two independent experiments is shown.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
Disclosures
 References
 
We show in this study for the first time that CD152 down-regulates the major effector cytokine IFN-{gamma} in primary and secondary stimulation of CD8 cells, whereas TNF-{alpha} is only regulated by CD152 upon restimulation of CD8 cells. The inhibition mediated by CD152 on IFN-{gamma} production of CD8 cells was shown to be independent of IL-2 or other soluble factors and is therefore cell-autonomous. Also, enhanced numbers of effector cells in CD152–/– CD8 cells were not the cause of enhanced cytokine production because proliferation was similar in WT and T cells with genetically inactivated CD152. Monitoring individual cells expressing IFN-{gamma} upon stimulation revealed that more IFN-{gamma}high cells were present when CD152 was inactivated. These novel functions in CD8 cells also have implications on CD152’s role in the generation of memory CD8 cells. Interestingly, we found that surface CD152 was expressed in much higher frequencies in individual, activated CD8 than Ag-stimulated CD4 cells. Our study showing the frequencies of CD152-expressing cells using the sensitive liposome technique, detecting as few as 100 molecules per cell, demonstrated that populations of Ag-specific stimulated CD8 cells have five times more CD152+ cells than CD4 cells and that the CD152 molecule was retained much longer on their surface than on CD4 cells. Hence, apart from activation and differentiation histories of an activated naive T cell, CD152 surface expression is also a cell intrinsic effect in which level and duration of expression depends on the T cell lineage. The higher fraction of CD152-expressing cells in CD8– than in CD4 populations in our study was probably not mediated by CD8-derived cytokines because it was reported previously that most cytokines, except IL-2 to a certain extent, did not markedly up-regulate CD152 (33). We found that even without addition of IL-2 to CD8 cultures during expansion, there was still a higher expression of surface CD152 on CD8 cells than on CD4 cells (data not shown). Moreover, cocultures of cells of both lineages propagated in the presence of IL-2 still resulted in a higher frequency of CD152+CD8 than CD4 T cells (data not shown). This shows that the expression of surface CD152 on CD8 T cells is a cell-intrinsic effect.

The functional relevance of this higher expression of CD152 and also its longer retention of the molecule on the surface of CD8 than on CD4 cells is largely unknown. But because CD152 has different functions in CD8 and in CD4 cells (e.g., in anergy induction), which at present are not precisely elucidated, this differential expression may be relevant in functions not performed by CD4 cells. Longer retention of CD152 on CD8 cells can mean that CD152 has an important function in much later phases of this cell type.

It has previously been shown that CD8 T cells from WT and 2C TCR transgenic mice express CD152 on the cell surface upon activation in vitro and that the proliferative response to anti-CD3 and anti-CD28 in vitro can be inhibited by additional CD152 cross-linking (14, 23). Although CD152 regulates CD8 cells, as far as antigenic responses are concerned, it has been implicated only in secondary CD8 responses (22). However, our studies for the first time illustrate that CD152 can also mediate its regulatory role during primary stimulation of CD8 cells with respect to IFN-{gamma} production. We have shown that genetic inactivation of CD152 in Ag-specific CD8 cells up-regulates IFN-{gamma} levels in the cultures dramatically. This effect of CD152 is probably not due to the overall activated status of ex vivo CD152–/– CD8 cells because only naive cells were isolated on the basis of their CD44low expression both in CD152WT and CD152–/– T cells, with the same stringent electronic gating during FACS sorting. Moreover, in these CD152–/– OT-1 mice, most CD8 cells are naive and are not activated due to CD152 deficiency until the age of 7 wk (14, 22). Thus, it is unlikely that CD8 cells from CD152-deficient mice have higher levels of the effector cytokine IFN-{gamma} due to enhanced activation status during the onset of stimulation compared with CD152WT cells. Our experiments showing that CD152WT cells cocultured with CD152–/– CD8 cells still have lower numbers of IFN-{gamma} producers, rule out the possibility that a soluble factor, possibly secreted by hyperactivated CD152–/– cells, is responsible for the overproduction of IFN-{gamma}. Moreover, TNF-{alpha} is shown to be unaffected by CD152 in primary CD8 cells, confirming similar activation status of CD152–/– and CD152WT CD8 T cells, respectively.

Detection of IFN-{gamma} production by individual cells of activated, Ag-specific primary CD8 cells from CD152–/– and CD152WT mice reveal that almost all the cells from both the cultures produce the cytokine, but, interestingly, there is a population of IFN-{gamma}high producers whose frequency is lower in CD152WT CD8 cultures than in CD152–/– cultures. This decrease in the frequency of effectors under the influence CD152 implies that CD152 regulates a small population of cells that may have an important functional relevance. This may reflect heterogeneity of T cells with respect to CD152 functions (17, 34), which may be a result of differential signaling of CD152 within a T cell population, depending possibly on its high or low expression levels on the surface of CD8 T cells.

Our data show that IFN-{gamma}high producers are regulated by CD152 signaling. Our finding is consistent with the concept that T cells receiving the strongest TCR signal express CD152 at the cell surface, which suggests that these cells are inhibited by CD152, and thus prevent the dominate response and avoid epitope spreading (28). It might also be that the cells expressing surface CD152 are the fittest (35) and are tightly controlled by CD152 signals to become memory cells (36, 37). Recently, it was reported that, in terms of Th1 memory responses, there are distinct lineages of Th1 cells with different capacities to develop into memory cells. Accordingly, IFN-{gamma}neg/low cells survive and develop into long-lived memory cells providing the overwhelming majority of long-term resting memory cells, in contrast to cells producing high amounts of IFN-{gamma} during primary responses. Considering our recent data that CD152 signaling protects CD4 Th cells from apoptosis (18), this is another way in which CD152 signaling could contribute even more to memory formation. Thus, heterogeneity of CD8 cells with respect to CD152 expression and signaling, associated with heterogeneity of IFN-{gamma} production, possibly contributes to long-term memory cell generation.

It is also interesting to note that only IFN-{gamma} but not TNF-{alpha} is down-regulated by CD152 in primary stimulated CD8 cells, illustrating independent regulation of TNF-{alpha} and IFN-{gamma} production by CD152 and hence bifurcation of CD152 signals. However, the fact that both of the cytokines are down-regulated dramatically by CD152 during secondary stimulation, rules out the argument that CD152 does not influence TNF-{alpha} at all. However, TNF-{alpha} not being regulated by CD152 in primary but only in secondary stimulated CD8 cells, raises the possibility that CD152 acts on TNF-{alpha} signaling depending on the activation history of CD8 cells and their CD152 surface expression. Another possible explanation is that very strong negative signals are needed to regulate TNF-{alpha} compared with those needed to down-regulate IFN-{gamma}. Thus, it is possible that, in a given T cell population, only high CD152 expression or high frequency of CD152+ cells can generate a strong enough negative CD152-mediated signal that could regulate TNF-{alpha} production. Because high frequencies of CD152+ cells are achieved earlier (day 2) in secondary than in primary stimulated CD8 cells and TNF-{alpha} is also only up-regulated at an early phase of an immune response, this could explain why TNF-{alpha} is down-regulated only in secondary stimulation. This result already illustrates the differential regulation of two different cytokines by CD152 signals. Another interesting observation from proliferation assays is that both CD152–/– and CD152WT cells proliferate with an equal number of cell divisions in all Ag- and CD3-stimulated CD8 T cell cultures as assessed by CFSE dilution assay. This result is a further indication that regulatory signals emanating from CD152 also bifurcate to control proliferative pathways and cytokine signals differentially.


   Acknowledgments
 
We like to thank Lisa Mendoza for critically reading the manuscript; Andreas Radbruch for discussion; Max Löhning for sending P14 mice; Gerd-Rüdiger Burmester for support; and A. Scheffold for technical support using liposomes for enhanced cytometric detection. We are also grateful to J. P. Allison for CD152–/– mice and R. Schwartz for P14 mice.


   Disclosures
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
References
 
The authors have no financial conflict of interest.


   Footnotes
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by the Gemeinnützige Hertie-Stiftung (to M.C.B.W.), Grant Deutsche Forschungsgemeinschaft Br1860/3 (to M.C.B.W.), NaFÖG Grant of Berlin (to P.P.), and a grant from Charité-Universitätsmedizin Berlin (to J.K.E.H.). Back

2 Current address: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892. Back

3 P.P. and J.K.E.H. contributed equally to this work. Back

4 Address correspondence and reprint requests to Dr. Monika C. Brunner-Weinzierl, Molecular Immunology, Deutsches Rheuma-Forschungszentrum, Schumannstrasse 21/22, Berlin, Germany. E-mail address: brunner{at}drfz.de Back

5 Abbreviations used in this paper: WT, wild type; KO, knockout; MFI, mean fluorescence intensity; neg, negative. Back

Received for publication May 15, 2006. Accepted for publication December 1, 2006.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 

  1. Kamijo, R., D. Shapiro, J. M. Le, S. Huang, M. Aguet, J. Vilcek. 1993. Generation of nitric-oxide and induction of major histocompatibility complex class-Ii antigen in macrophages from mice lacking the interferon-{gamma} receptor. Proc. Natl. Acad. Sci. USA 90: 6626-6630. [Abstract/Free Full Text]
  2. Refaeli, Y., L. Van Parijs, S. I. Alexander, A. K. Abbas. 2002. Interferon {gamma} is required for activation-induced death of T lymphocytes. J. Exp. Med. 196: 999-1005. [Abstract/Free Full Text]
  3. Bossie, A., E. S. Vitetta. 1991. IFN-{gamma} enhances secretion of Igg2A from Igg2A-committed Lps-stimulated murine B-cells: implications for the role of IFN-{gamma} in class switching. Cell. Immunol. 135: 95-104. [Medline]
  4. Snapper, C. M., W. E. Paul. 1987. Interferon-{gamma} and B-cell stimulatory factor-I reciprocally regulate Ig isotype production. Science 236: 944-947. [Abstract/Free Full Text]
  5. Das, G., S. Sheridan, C. A. Janeway. 2001. The source of early IFN-{gamma} that plays a role in Th1 priming. J. Immunol. 167: 2004-2010. [Abstract/Free Full Text]
  6. Zhang, Y. K., R. Apilado, J. Coleman, S. Ben-Sasson, S. Tsang, J. Hu-Li, W. E. Paul, H. Huang. 2001. Interferon {gamma} stabilizes the T helper cell type 1 phenotype. J. Exp. Med. 194: 165-172. [Abstract/Free Full Text]
  7. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R. M. Zinkernagel, M. Aguet. 1993. Immune-response in mice that lack the interferon-{gamma} receptor. Science 259: 1742-1745. [Abstract/Free Full Text]
  8. Kamijo, R., J. Le, D. Shapiro, E. A. Havell, S. Huang, M. Aguet, M. Bosland, J. Vilcek. 1993. Mice that lack the interferon-{gamma} receptor have profoundly altered responses to infection with bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide. J. Exp. Med. 178: 1435-1440. [Abstract/Free Full Text]
  9. Buchmeier, N. A., R. D. Schreiber. 1985. Requirement of endogenous interferon-{gamma} production for resolution of Listeria monocytogenes infection. Proc. Natl. Acad. Sci. USA 82: 7404-7408. [Abstract/Free Full Text]
  10. Dighe, A. S., E. Richards, L. J. Old, R. D. Schreiber. 1994. Enhanced in-vivo growth and resistance to rejection of tumor-cells expressing dominant-negative IFN-{gamma} receptors. Immunity 1: 447-456. [Medline]
  11. Brunner, M. C., C. A. Chambers, F. K. Chan, J. Hanke, A. Winoto, J. P. Allison. 1999. CTLA-4-mediated inhibition of early events of T cell proliferation. J. Immunol. 162: 5813-5820. [Abstract/Free Full Text]
  12. Brunner, M. C.. 1999. Costimulatory molecules and modulation. Immunologist 7: 9-12.
  13. Brunet, J. F., F. Denizot, M. F. Luciani, M. Rouxdosseto, M. Suzan, M. G. Mattei, P. Golstein. 1987. A new member of the immunoglobulin superfamily-Ctla-4. Nature 328: 267-270. [Medline]
  14. Walunas, T. L., D. J. Lenschow, C. Y. Bakker, P. S. Linsley, G. J. Freeman, J. M. Green, C. B. Thompson, J. A. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1: 405-413. [Medline]
  15. Chambers, C. A., M. F. Krummel, B. Boitel, A. Hurwitz, T. J. Sullivan, S. Fournier, D. Cassell, M. Brunner, J. P. Allison. 1996. The role of CTLA-4 in the regulation and initiation of T-cell responses. Immunol. Rev. 153: 27-46. [Medline]
  16. Martin, M., H. Schneider, A. Azouz, C. E. Rudd. 2001. Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function. J. Exp. Med. 194: 1675-1681. [Abstract/Free Full Text]
  17. Maszyna, F., H. Hoff, D. Kunkel, A. Radbruch, M. C. Brunner-Weinzierl. 2003. Diversity of clonal T cell proliferation is mediated by differential expression of CD152 (CTLA-4) on the cell surface of activated individual T lymphocytes. J. Immunol. 171: 3459-3466. [Abstract/Free Full Text]
  18. Pandiyan, P., D. Gartner, O. Soezeri, A. Radbruch, K. Schulze-Osthoff, M. C. Brunner-Weinzierl. 2004. CD152 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activation-induced cell death by a mechanism requiring PI3 kinase function. J. Exp. Med. 199: 831-842. [Abstract/Free Full Text]
  19. Greenwald, R. J., V. A. Boussiotis, R. B. Lorsbach, A. K. Abbas, A. H. Sharpe. 2001. CTLA-4 regulates induction of anergy in vivo. Immunity 14: 145-155. [Medline]
  20. Frauwirth, K. A., M. L. Alegre, C. B. Thompson. 2001. CTLA-4 is not required for induction of CD8+ T cell anergy in vivo. J. Immunol. 167: 4936-4941. [Abstract/Free Full Text]
  21. Probst, H. C., K. Mccoy, T. Okazaki, T. Honjo, M. F. van den Broek. 2005. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Immunology 116: 43
  22. Chambers, C. A., T. J. Sullivan, T. Truong, J. P. Allison. 1998. Secondary but not primary T cell responses are enhanced in CTLA-4-deficient CD8+ T cells. Eur. J. Immunol. 28: 3137-3143. [Medline]
  23. Krummel, M. F., J. P. Allison. 1995. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182: 459-465. [Abstract/Free Full Text]
  24. Walunas, T. L., C. Y. Bakker, J. A. Bluestone. 1996. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183: 2541-2550. [Abstract/Free Full Text]
  25. Homann, D., W. Dummer, T. Wolfe, E. Rodrigo, A. N. Theofilopoulos, M. B. A. Oldstone, M. G. von Herrath. 2006. Lack of intrinsic CTLA-4 expression has minimal effect on regulation of antiviral T-cell immunity. J. Virol. 80: 270-280. [Abstract/Free Full Text]
  26. Shrikant, P., A. Khoruts, M. F. Mescher. 1999. CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell-and IL-2-dependent mechanism. Immunity 11: 483-493. [Medline]
  27. Hope, M. J., M. B. Bally, G. Webb, P. R. Cullis. 1985. Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential. Biochim. Biophys. Acta 812: 55-65.
  28. Egen, J. G., J. P. Allison. 2002. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 16: 23-35. [Medline]
  29. Krummel, M. F., J. P. Allison. 1996. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183: 2533-2540. [Abstract/Free Full Text]
  30. Scheffold, A., M. Assenmacher, L. Reiners-Schramm, R. Lauster, A. Radbruch. 2000. High-sensitivity immunofluorescence for detection of the pro- and anti-inflammatory cytokines {gamma} interferon and interleukin-10 on the surface of cytokine-secreting cells. Nat. Med. 6: 107-110. [Medline]
  31. Gartner, D., H. Hoff, U. Gimsa, G. R. Burmester, M. C. Brunner-Weinzierl. 2006. CD25 regulatory T cells determine secondary but not primary remission in EAE: impact on long-term disease progression. J. Neuroimmunol. 172: 73-84. [Medline]
  32. Zheng, L., G. Fisher, R. E. Miller, J. Peschon, D. H. Lynch, M. J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377: 348-351. [Medline]
  33. Alegre, M. L., P. J. Noel, B. J. Eisfelder, E. Chuang, R. Clark, S. L. Reiner, C. B. Thompson. 1996. Regulation of surface and intracellular expression of CTLA-4 on mouse T cells. J. Immunol. 157: 4762[Abstract]
  34. Egen, J. G., M. S. Kuhns, J. P. Allison. 2002. CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat. Immunol. 3: 611-618. [Medline]
  35. Gett, A. V., F. Sallusto, A. Lanzavecchia, J. Geginat. 2003. T cell fitness determined by signal strength. Nat. Immunol. 4: 355-360. [Medline]
  36. Hayashi, N., D. Liu, S. Min, Z. Ben-Sasson, W. E. Paul. 2002. Antigen challenge leads to in vivo activation and elimination of highly polarized TH1 memory T cells. Proc. Natl. Acad. Sci. USA 99: 6187-6191. [Abstract/Free Full Text]
  37. Wu, C. Y., J. R. Kirman, M. J. Rotte, D. F. Davey, S. P. Perfetto, E. J. Rhee, B. L. Freidag, B. J. Hill, D. C. Douek, R. A. Seder. 2002. Distinct lineages of TH1 cells have differential capacities for memory cell generation in vivo. Nat. Immunol. 3: 797-798. [Medline]



This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
M. J. Callahan, Z. Nagymanyoki, T. Bonome, M. E. Johnson, B. Litkouhi, E. H. Sullivan, M. S. Hirsch, U. A. Matulonis, J. Liu, M. J. Birrer, et al.
Increased HLA-DMB Expression in the Tumor Epithelium Is Associated with Increased CTL Infiltration and Improved Prognosis in Advanced-Stage Serous Ovarian Cancer
Clin. Cancer Res., December 1, 2008; 14(23): 7667 - 7673.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Quandt, H. Hoff, M. Rudolph, S. Fillatreau, and M. C. Brunner-Weinzierl
A New Role of CTLA-4 on B Cells in Thymus-Dependent Immune Responses In Vivo
J. Immunol., December 1, 2007; 179(11): 7316 - 7324.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pandiyan, P.
Right arrow Articles by Brunner-Weinzierl, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pandiyan, P.
Right arrow Articles by Brunner-Weinzierl, M. C.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS